AGA
Arkos Global Advisors’s Boston Scientific BSX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $647K | Hold |
6,023
| – | – | 0.09% | 58 |
|
|
2025
Q1 | $608K | Hold |
6,023
| – | – | 0.09% | 61 |
|
|
2024
Q4 | $538K | Sell |
6,023
-351
| -6% | -$31.4K | 0.08% | 65 |
|
|
2024
Q3 | $534K | Buy |
6,374
+30
| +0.5% | +$2.51K | 0.08% | 65 |
|
|
2024
Q2 | $489K | Hold |
6,344
| – | – | 0.08% | 67 |
|
|
2024
Q1 | $435K | Hold |
6,344
| – | – | 0.07% | 77 |
|
|
2023
Q4 | $367K | Sell |
6,344
-454
| -7% | -$26.3K | 0.07% | 71 |
|
|
2023
Q3 | $359K | Hold |
6,798
| – | – | 0.07% | 65 |
|
|
2023
Q2 | $368K | Sell |
6,798
-500
| -7% | -$27.1K | 0.07% | 63 |
|
|
2023
Q1 | $365K | Hold |
7,298
| – | – | 0.07% | 63 |
|
|
2022
Q4 | $338K | Sell |
7,298
-1,000
| -12% | -$46.3K | 0.09% | 66 |
|
|
2022
Q3 | $321K | Sell |
8,298
-4,180
| -33% | -$162K | 0.1% | 58 |
|
|
2022
Q2 | $465K | Buy |
12,478
+1,625
| +15% | +$60.6K | 0.13% | 45 |
|
|
2022
Q1 | $481K | Hold |
10,853
| – | – | 0.13% | 48 |
|
|
2021
Q4 | $461K | Sell |
10,853
-500
| -4% | -$21.2K | 0.14% | 51 |
|
|
2021
Q3 | $493K | Hold |
11,353
| – | – | 0.17% | 40 |
|
|
2021
Q2 | $485K | Hold |
11,353
| – | – | 0.17% | 43 |
|
|
2021
Q1 | $439K | Hold |
11,353
| – | – | 0.17% | 45 |
|
|
2020
Q4 | $408K | Hold |
11,353
| – | – | 0.17% | 46 |
|
|
2020
Q3 | $434K | Sell |
11,353
-114
| -1% | -$4.36K | 0.2% | 42 |
|
|
2020
Q2 | $403K | Hold |
11,467
| – | – | 0.21% | 51 |
|
|
2020
Q1 | $374K | Buy |
+11,467
| New | +$374K | 0.25% | 45 |
|